GR3033961T3 - Human calcium channel compositions and methods. - Google Patents

Human calcium channel compositions and methods.

Info

Publication number
GR3033961T3
GR3033961T3 GR20000401646T GR20000401646T GR3033961T3 GR 3033961 T3 GR3033961 T3 GR 3033961T3 GR 20000401646 T GR20000401646 T GR 20000401646T GR 20000401646 T GR20000401646 T GR 20000401646T GR 3033961 T3 GR3033961 T3 GR 3033961T3
Authority
GR
Greece
Prior art keywords
human calcium
methods
calcium channel
channel compositions
compositions
Prior art date
Application number
GR20000401646T
Other languages
English (en)
Inventor
Michael Miller Harpold
Steven Bradley Ellis
Mark Edward Williams
Daniel Howard Feldman
Ann Francis Mccue
Robert Brenner
Original Assignee
Salk Inst Biotech Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/745,206 external-priority patent/US5429921A/en
Application filed by Salk Inst Biotech Ind filed Critical Salk Inst Biotech Ind
Publication of GR3033961T3 publication Critical patent/GR3033961T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
GR20000401646T 1991-08-15 2000-07-17 Human calcium channel compositions and methods. GR3033961T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/745,206 US5429921A (en) 1988-04-04 1991-08-15 Assays for agonists and antagonists of recombinant human calcium channels
US86835492A 1992-04-10 1992-04-10
PCT/US1992/006903 WO1993004083A1 (en) 1991-08-15 1992-08-14 Human calcium channel compositions and methods

Publications (1)

Publication Number Publication Date
GR3033961T3 true GR3033961T3 (en) 2000-11-30

Family

ID=27114421

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401646T GR3033961T3 (en) 1991-08-15 2000-07-17 Human calcium channel compositions and methods.

Country Status (10)

Country Link
EP (3) EP0598840B1 (el)
JP (1) JPH06509717A (el)
AT (2) ATE191920T1 (el)
AU (1) AU677571B2 (el)
CA (1) CA2113203C (el)
DE (2) DE69233469T2 (el)
DK (1) DK0598840T3 (el)
ES (2) ES2235417T3 (el)
GR (1) GR3033961T3 (el)
WO (1) WO1993004083A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874236A (en) * 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US6387696B1 (en) * 1988-04-04 2002-05-14 Merck & Co., Inc. Human calcium channel compositions and methods
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
US5876958A (en) * 1988-04-04 1999-03-02 Sibia Neurosciences, Inc. Assays of cells expressing human calcium channels containing α1 β subunits
US5912122A (en) * 1993-06-04 1999-06-15 Sibia Neurosciences, Inc. Nucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6
US5623051A (en) * 1994-11-10 1997-04-22 University Of Washington Methods and compositions for screening for presynaptic calcium channel blockers
US5712158A (en) * 1995-06-06 1998-01-27 Warner-Lambert Company Cell line for the rapid expression of functional calcium channels
US6040436A (en) * 1996-09-16 2000-03-21 American Home Products Corporation Nucleic acid encoding human neuronal calcium channel subunits
WO1999028342A2 (en) * 1997-12-03 1999-06-10 Merck & Co., Inc. Low-voltage activated calcium channel compositions and methods
WO1999029847A1 (en) * 1997-12-05 1999-06-17 Loyola University Of Chicago T-type voltage-gated calcium channels and method of using same
AU770018B2 (en) 1998-03-13 2004-02-12 Brown University Research Foundation Human N-type calcium channel isoform and uses thereof
WO1999063078A2 (en) 1998-06-02 1999-12-09 University Technologies International Inc. Retinal calcium channel (alpha)1f-subunit gene
EP1173571A2 (en) * 1999-05-05 2002-01-23 Lexicon Genetics Incorporated Human ion channel proteins
JP2003512602A (ja) 1999-09-16 2003-04-02 ワーナー−ランバート・カンパニー α2δ−1サブユニット結合リガンドのスクリーニング方法
US6962973B1 (en) 1999-09-16 2005-11-08 Warner-Lambert Company Porcine α2δ-1 calcium channel subunit cDNA and soluble secreted α2δ-1 subunit polypeptides
US6783952B1 (en) 1999-09-16 2004-08-31 Warner-Lambert Company Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same
US7067714B1 (en) 1999-10-26 2006-06-27 Eisai Research Institute N-calcium channel knockout animal
WO2001030137A1 (fr) * 1999-10-26 2001-05-03 Eisai Co. Ltd. Animal knockout a canal n-calcium
US7294691B1 (en) 2000-09-18 2007-11-13 Warner Lambert Company Soluble secreted α2δ-2calcium channel subunit polypeptide
US20050208044A1 (en) 2002-03-19 2005-09-22 Jane Barclay Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
ATE139542T1 (de) * 1988-04-04 1996-07-15 Salk Inst Biotech Ind Calciumkanal-zusammensetzungen und verfahren
DE4110785A1 (de) * 1991-04-04 1992-10-08 Bayer Ag Gewebe-spezifische humane neuronale calcium-kanal-subtypen und deren verwendung

Also Published As

Publication number Publication date
CA2113203C (en) 2001-01-02
EP0598840A1 (en) 1994-06-01
AU677571B2 (en) 1997-05-01
AU2495792A (en) 1993-03-16
EP0992585A2 (en) 2000-04-12
EP0598840B1 (en) 2000-04-19
ATE191920T1 (de) 2000-05-15
DE69230938T2 (de) 2000-10-12
CA2113203A1 (en) 1993-03-04
DE69233469T2 (de) 2005-12-22
DE69230938D1 (de) 2000-05-25
EP1469074B1 (en) 2008-11-26
EP0992585B1 (en) 2005-01-12
EP0992585A3 (en) 2000-11-15
ES2235417T3 (es) 2005-07-01
EP1469074A1 (en) 2004-10-20
ATE286976T1 (de) 2005-01-15
DK0598840T3 (da) 2000-10-02
DE69233469D1 (de) 2005-02-17
ES2147184T3 (es) 2000-09-01
WO1993004083A1 (en) 1993-03-04
JPH06509717A (ja) 1994-11-02

Similar Documents

Publication Publication Date Title
EP0424397A4 (en) Calcium channel compositions and methods
GR3033961T3 (en) Human calcium channel compositions and methods.
GB9503692D0 (en) Human calcium channel compositions and methods of using them
WO1999028342A3 (en) Low-voltage activated calcium channel compositions and methods
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
ES2036192T3 (es) Derivados del acido (met)-acrilico, que contienen grupos uretano, de triciclo (5.2.1.0.2.6) decano.
ES8900017A1 (es) Procedimiento para la preparacion de dipeptidos de n,n-dialquil-guanidino.
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
IL88531A (en) Cognitive enhancing compositions containing d-cycloserine
GR3034855T3 (en) Dna encoding a human calcium channel alpha-1e subunit
AU2271788A (en) Polyethylene stabilized by mixture of hindered phenol and amine antioxidants
BG101002A (en) Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
DE69729211D1 (en) Tetrahydro-beta carbolinverbindungen
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
ES2000320A6 (es) Procedimiento para la preparacion de compuestos de 1-oxa-3-oxo-4,8-diaza-espiro (4,5) decano
IE55801B1 (en) Novel vitamin d analogs
EP0270782A3 (en) Therapeutic agents for the prophylaxis of tumour metastasis
MY102026A (en) Antiasthmatic.
NO170936C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte vinylcefalosporiner
ES8505540A1 (es) Procedimiento para la obtencion de alcoxiaril-alcanoles
NO921491L (no) Indol- og dihydrokinolinaapnere for kaliumkanal
AU4343097A (en) Nucleic acid encoding human neuronal calcium channel subunits
US4916140B1 (el)
NZ211311A (en) Hair growth stimulating compositions containing prolactin secretion stimulating agents
UA10769C2 (uk) Лікарський засіб для профілактики передчасhого старіhhя та лікуваhhя вікових патологій

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20110302